Niti Aayog's roadmap to turn India into $691 billion bioeconomy

Niti Aayog has proposed a major overhaul of India's biotechnology strategy, recommending the country to replace fragmented programmes with six mission-driven national initiatives, accelerating growth in the sector. These recommendations come as part of its newly released bioeconomy roadmap, which sets a target of building a $691 billion bioeconomy by 2035.The roadmap mentioned that the shift to a mission-based framework is needed to strengthen capabilities across healthcare, agriculture, industrial biotechnology and disease surveillance, while ensuring research translates into globally competitive products and large-scale manufacturing."These are designed to build sovereign capabilities across advanced therapeutics, climate-resilient agriculture, synthetic biology platforms, pandemic preparedness, blue-economy innovation and next-generation biologics," the roadmap stated.Under the proposed framework, GeneIndia will focus on expanding access to affordable gene and cell therapies as well as precision diagnostics.